These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


85 related items for PubMed ID: 3266509

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Recent topics on Alzheimer's disease. Alzheimer's disease from the viewpoint of the free radical theory].
    Kobayashi K.
    Nihon Rinsho; 1988 Jul; 46(7):1616-22. PubMed ID: 3221469
    [No Abstract] [Full Text] [Related]

  • 3. Monoamine oxidase-B, monoamine oxidase-B inhibitors, and Parkinson's disease. A role for superoxide dismutase?
    Sandler M, Glover V, Clow A, Jarman J.
    Adv Neurol; 1993 Jul; 60():238-41. PubMed ID: 8420141
    [No Abstract] [Full Text] [Related]

  • 4. [Biochemistry of the physiopathologic and clinical aspects of free radicals in liver and pancreatic diseases].
    Kamada T, Sato N, Matsumura T, Miyamoto T.
    Nihon Rinsho; 1988 Oct; 46(10):2236-40. PubMed ID: 2853788
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Biochemistry of the physiopathologic and clinical aspects of free radicals in shock and disseminated intravascular coagulation].
    Ogawa R.
    Nihon Rinsho; 1988 Oct; 46(10):2196-202. PubMed ID: 2853782
    [No Abstract] [Full Text] [Related]

  • 8. [Nervous system and free radicals].
    Hirai S.
    No To Shinkei; 1992 Jul; 44(7):595-604. PubMed ID: 1329887
    [No Abstract] [Full Text] [Related]

  • 9. Free radicals, lipid peroxidation, and Parkinson's disease.
    Smith MT, Sandy MS, Di Monte D.
    Lancet; 1987 Jan 03; 1(8523):38. PubMed ID: 2879109
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Toxins and Parkinson's disease: MPTP parkinsonism in humans and animals.
    Kopin IJ.
    Adv Neurol; 1987 Jan 03; 45():137-44. PubMed ID: 3493621
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Targeting programmed cell death in neurodegenerative diseases.
    Vila M, Przedborski S.
    Nat Rev Neurosci; 2003 May 03; 4(5):365-75. PubMed ID: 12728264
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Pethidine and parkinsonism. 1-Metyl-4-phenyl-1,2,3,6-tetrahydroxypyridine, a new neurotoxin].
    Hunskår S.
    Tidsskr Nor Laegeforen; 1986 Jan 30; 106(3):219-20. PubMed ID: 3485316
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.